Full-Time

Territory Manager

Animal Health, Pensacola|FL

Posted on 10/1/2025

Cencora

Cencora

10,001+ employees

Global pharmaceutical distribution and services provider

No salary listed

Pensacola, FL, USA

In Person

Category
Sales & Account Management (1)
Required Skills
Market Research
Inventory Management
Customer Service
Requirements
  • A bachelor’s degree and one to three years of outside sales experience, preferably in animal health, are desired.
  • A valid drivers’ license and good driving record are mandatory.
  • Speak Effectively: Speaks effectively in individual or group situations (e.g., meetings, presentations, interviews) including appropriate nonverbal communications; able to recognize and present information to others; recognizes different methods for communicating the same information and selects the best method; strives for positive high impact delivery.
  • Customer Service: Is customer oriented, sensitive and responsive to customer needs and priorities; establishes effective working relationships with customers and gains their respect and loyalty; identifies and takes appropriate action on customer needs.
  • Know the Organization: Understands the company’s objectives; knows the structure of the organization; works effectively within the organization to achieve results; works continuously to make linkages and build networks within the organization.
  • Know the Customer and the Market: Knows customers in the market territory; keeps up to date on key competitors; understands and is responsive to the needs and expectations of relevant customer segments; establishes effective working relationships with customers to gain respect and loyalty; identifies opportunities presented by changes and shifts in the marketplace.
  • Build Quality Service: Defines quality service based on customer needs, wants, expectations and profitability; aligns actions accordingly; remains sensitive and responsive to both internal and external customers; builds distinctive predictable levels of service; resolves problems quickly and effectively.
  • Know the Product: Displays knowledge and proficiency in explaining, selling, and administering products; refers customers to appropriate resources within the organization.
  • Maintain Technological Expertise: Keeps informed of technological advances affecting the industry; recognizes/identifies appropriate and effective technological applications for use by the company; applies internal technology to effective advantage.
  • Demonstrate Interpersonal Skills: Communicates in an open, straight forward, honest and respectful style; checks for message clarity; understands the effect the communication style has on others, including nonverbal communications; plans for and adapts to the wide variety of communication preferences and needs of others.
Responsibilities
  • Call on target, current and prospective customers in order to generate sales, improve market share, and increase income for MWI.
  • Utilize the computer as a sales aid and be competent in the use of MWI e-mail, MWI promotions in Outlook, and the MWI Territory Manager website.
  • Seek to understand the needs of the veterinarian and clinic and, in turn, select products and services to satisfy those needs.
  • Establish appropriate relationships with veterinarians and clinics.
  • Review and utilize sales analysis and top supplier reports in pre and post call planning.
  • Prepare and maintain a written call cycle consistent with territory changes. Share information with ISR and Regional Manager .Call cycle information includes account number, name, location, and day of the week.
  • Stay current on the full line of products and services offered by MWI.
  • Demonstrate competency in MWI sales programs, promotions and products.
  • Establish account profiles for customers within territory .Be responsive to communication from customers, MWI team members, and manufacturer representatives.
  • Detail and/or demonstrate new products and promotions for customers.
  • Ensure reporting is submitted timely.
  • Meet sales goals and budget numbers by territory and manufacturer.
  • Act as a resource to the customer in business matters dealing with such issues as inventory management, equipment and products.
  • Act as point person for customers on nearly all dealings with the company; work with MWI inside personnel to ensure customer issues are resolved.
  • Maintain vehicle in a professional manner.
  • Work closely with key vendors and Product Specialists.
  • Maintain adequate support material and detail aids in automobile.
  • Comply with other requests from MWI Regional Managers and leadership.
  • Participate in conference calls and meetings as req
Desired Qualifications
  • A bachelor’s degree and one to three years of outside sales experience, preferably in animal health, are desired.

Cencora provides global pharmaceutical distribution and a range of services, including specialty pharmacy, consulting, supply-chain management, patient support programs, and data analytics for healthcare providers, manufacturers, and veterinary practices. It works by combining physical drug distribution with value-added services such as inventory management, regulatory compliance guidance, patient support, and data-driven insights to optimize supply chains and outcomes. The company differentiates itself with an integrated, end-to-end offering that spans distribution, clinical services, analytics, and advisory support to help clients run more efficient operations and lower costs. Its goal is to improve healthcare outcomes by delivering comprehensive pharmaceutical solutions that enable better care and lower overall expenses.

Company Size

10,001+

Company Stage

IPO

Headquarters

Pennsylvania

Founded

1907

Simplify Jobs

Simplify's Take

What believers are saying

  • OneOncology $5B acquisition completed December 2025 boosts specialty oncology leadership.
  • EyeSouth retina business $1.1B deal expands Retina Consultants, accretive to EPS post-closure.
  • FY2026 EPS guidance raised to $17.65–$17.90 despite revenue headwinds from biosimilars.

What critics are saying

  • Frank R. Cruz investigation triggers shareholder lawsuits after May 6, 2026 Q2 revenue miss.
  • McKesson and Cardinal Health seize specialty drug share via aggressive GLP-1 pricing.
  • Inflation Reduction Act price cuts compress margins beyond $2B Q2 2026 headwind.

What makes Cencora unique

  • Cencora rebranded from AmerisourceBergen in August 2023, trading as COR on NYSE.
  • Cencora operates 1,400 locations across 50+ countries for global pharmaceutical distribution.
  • Cencora uniquely serves human and animal health with specialty pharmacy and MSO platforms.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 23rd, 2026
Cencora buys EyeSouth Partners' retina business for $1.1B to expand Retina Consultants of America

Cencora has signed a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. The affiliated retina physicians will join Cencora's Retina Consultants of America, a leading management services organisation. The pharmaceutical solutions company expects the acquisition to be slightly accretive to its adjusted diluted earnings per share in the first twelve months following closure, net of financing costs. The transaction requires regulatory approvals and customary closing conditions. Cencora's reaffirmed fiscal 2026 financial guidance does not currently include the transaction closing within that fiscal year. BofA Securities served as lead financial advisor to Cencora, whilst Jefferies advised EyeSouth Partners, a portfolio company of Olympus Partners.

The Associated Press
Mar 17th, 2026
Cencora CFO James Cleary to retire after eight years, search underway for successor

Cencora has announced that Chief Financial Officer James F. Cleary will retire effective 30 June 2026. The pharmaceutical solutions company has engaged an executive search firm to identify potential successors from internal and external candidates. Cleary, 62, has served as CFO since November 2018 and joined Cencora in February 2015 following its acquisition of MWI Veterinary Supply, where he had been chief executive officer for over a decade. He will serve in an advisory capacity through the end of 2026 to ensure a smooth transition. Cencora reaffirmed its previously issued adjusted diluted earnings per share guidance range of $17.45 to $17.75 for fiscal year 2026. The company, ranked number 10 on the Fortune 500, generates more than $300 billion in annual revenue.

TradingView
Feb 11th, 2026
Cencora prices $3B senior notes offering across multiple maturities

Cencora has priced a $3 billion senior notes offering across various maturities, the company announced on 10 February 2026. No further details about the specific maturities, interest rates or intended use of proceeds were disclosed in the announcement.

Yahoo Finance
Feb 4th, 2026
Cencora raises fiscal 2026 guidance after completing OneOncology acquisition

Cencora reported 12% adjusted operating income growth and 9% adjusted diluted EPS growth in its fiscal 2026 first quarter, driven by its US healthcare solutions business. The company raised its full-year guidance to reflect year-over-year adjusted operating income growth of 11.5% to 13.5%. CEO Robert Mauch announced the completion of Cencora's acquisition of the majority remaining equity interest in OneOncology. The deal strengthens Cencora's specialty pharmaceutical leadership and MSO (management services organisation) platform. Cencora's strategy focuses on three priorities: strengthening leadership in specialty pharmaceuticals, partnering with market leaders, and enhancing patient access to pharmaceuticals. The company is leveraging technology and advanced analytics to improve customer experience and operational excellence whilst expanding its pharmaceutical-centric MSO footprint.

Yahoo Finance
Feb 4th, 2026
Cencora beats profit estimates on specialty drug demand, completes $5B OneOncology acquisition

Cencora beat Wall Street's first-quarter profit estimates on Wednesday, driven by sustained demand for specialty medicines and GLP-1 therapies. The drug distributor reported adjusted earnings of $4.08 per share, exceeding analysts' expectations of $4.04. The company completed its $5 billion acquisition of OneOncology from TPG in December, strengthening its presence in cancer care. It raised its fiscal 2026 adjusted operating income growth forecast to 11.5% to 13.5%, up from 8% to 10% previously. However, quarterly revenue of $85.93 billion fell short of expectations of $86.03 billion, sending shares down 5% in pre-market trading. Sales at its largest unit, US healthcare solutions, rose 5% year-over-year to $76.2 billion, boosted by prescription volumes of weight-loss drugs and specialty medicines.

INACTIVE